Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/17/2017 07/18/2017 07/19/2017 07/20/2017 07/21/2017 Date
111.85(c) 109.95(c) 111.15(c) 112.05(c) 111(c) Last
1 162 519 2 111 991 1 568 717 2 034 299 3 449 373 Volume
-0.80% -1.70% +1.09% +0.81% -0.94% Change
More quotes
Financials (€)
Sales 2017 49 989 M
EBIT 2017 9 577 M
Net income 2017 5 702 M
Debt 2017 11 275 M
Yield 2017 2,55%
Sales 2018 52 452 M
EBIT 2018 10 348 M
Net income 2018 6 313 M
Debt 2018 10 080 M
Yield 2018 2,74%
P/E ratio 2017 17,22
P/E ratio 2018 15,67
EV / Sales2017 2,06x
EV / Sales2018 1,94x
Capitalization 91 791 M
More Financials
Company
Bayer AG is engaged in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the Healthcare, Crop Science and Material Science subgroups, which are supported by three service companies.The Healthcare subgroup... 
Sector
Pharmaceuticals
Calendar
07/27 | 07:30amEarnings Release
More about the company
Surperformance© ratings of Bayer
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER
09:54a BAYER : Sens. Klobuchar, Merkley, Senators Urge DOJ Antitrust Division to Conduc..
07/20 BAYER : Patent Issued for Soybean Variety ELL0254 (USPTO 9699984)
07/20 BAYER : and White Ribbon Alliance Partnership Reaches 1,200 Women in 91 Communit..
07/20 BAYER : Study Data from Bayer Update Understanding of Prostate Cancer (Exploitin..
07/20 BAYER : Data on Chemical Biology Detailed by Researchers at Bayer (Novel Class o..
07/20 BAYER : Findings on Heart Failure Reported by Investigators at Bayer [Discovery ..
07/20 DGAP-AFR : Bayer Aktiengesellschaft: Preliminary announcement of the publication..
07/18 COVESTRO : Global Hexamethylene Diisocyanate (HDI) Market Segmentation and Indus..
07/14 BAYER : and White Ribbon Alliance Partnership Reaches 1,200 Women in 91 Communit..
07/14 BAYER : $29,036 Federal Contract Awarded to Bayer Healthcare
More news
Sector news : Pharmaceuticals - NEC
07/21 FTSE, sheltered from euro strength, has best week since May
07/21DJGLAXOSMITHKLINE : FDA Approves Injectable Form Of Glaxo's Benlysta
07/21 GlaxoSmithKline's new CEO prepares to trim drug pipeline
07/21 AstraZeneca CEO reassures staff, aims to be at September cancer meet
07/20 Abbott profit forecast gets a lift from St. Jude integration
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on BAYER 
2016Good timing to anticipate the return of volatility
2016A technical turn-around configuration
More Strategies
Latest Tweets
04:02aBayern battle Milan tonight: The pre-season tournament clash between Bundesli.. 
02:10aBayer says asbestos-related tumor treatment misses key goal
1
12:07aBayer faces EU test in race to close Monsanto deal by year-end  
07/21Bayer’s blockbuster pipeline promises broken by a PhII setback for top cancer.. 
07/21Bayer says asbestos-related tumor treatment misses key goal
3
More tweets
Qtime:205
News from SeekingAlpha
07/21 Bayer's anetumab ravtansine flunks mid-stage MPM study
07/21 No Fruitful Harvest For Farmland Partners
07/21 European advisory group backs expanded use of Bayer's Xarelto
07/19 Greenlight Capital Q2 Letter
07/12 CLIMATE CHANGE INVESTING : Momentum Building, Trump Notwithstanding
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 121 €
Spread / Average Target 8,7%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER11.97%107 019
JOHNSON & JOHNSON17.45%364 503
ROCHE HOLDING LTD.5.46%221 492
NOVARTIS9.72%220 936
PFIZER3.08%199 378
MERCK AND COMPANY6.39%171 303